-- Cue Biopharma (CUE) shares soared 144% a day after the company said it signed a roughly $30 million PIPE financing with certain investors, and also appointed Shao-Lee Lin as president and chief executive.
More than 16.3 million shares of the company traded intraday compared with a daily average of about 356,000.
Hemab Therapeutics (COAG) said Thursday it priced its initial public offering of 16.8 million shares at $18 per share for gross proceeds of $301.5 million.
Shares, which began trading on the Nasdaq Global Select Market on Friday, were up 66% intraday, with a trading volume of 1.87 million.
Twilio (TWLO) delivered Q1 results that exceeded expectations, with accelerating momentum across AI-driven use cases and stronger-than-expected business performance, Morgan Stanley said Friday in a report.
Shares surged 20%, with intraday trading volume at over 4.44 million from a daily average of roughly 2.44 million.
Price: $34.70, Change: $+19.96, Percent Change: +135.41%